Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
32 participants
INTERVENTIONAL
2013-06-26
2016-02-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Appropriate Gestational Weight Gain in Overweight/Obese Women
NCT02130232
Promoting Healthy Weight Gain During Pregnancy
NCT01117961
Weight Management for Improved Pregnancy Outcomes
NCT00950235
A Mobile Health Intervention to Achieve Appropriate Gestational Weight Gain in Overweight/Obese Women
NCT03880461
Personalized Management of Body Weight During Pregnancy
NCT01610752
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Arm
Participants in this group were informed to continue to receive usual care.
No interventions assigned to this group
Intervention Arm
Received an interactive physical activity monitoring system (the Gruve®).
Intervention
Participants received a interactive physical activity monitoring system that allowed study personnel to monitor their activity level.
Intervention Arm 2
Received an interactive physical activity monitoring system (the Gruve®) and group based phone counseling (GBPC).
Intervention 2
Participants received an interactive physical activity monitoring system, an electronic scale to report weekly body weight, weekly hour long conference calls with structured interactive educational lessons led by Health Educator, dietary recalls were completed at three different time points during their participation, and study personnel monitored physical activity levels weekly.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intervention
Participants received a interactive physical activity monitoring system that allowed study personnel to monitor their activity level.
Intervention 2
Participants received an interactive physical activity monitoring system, an electronic scale to report weekly body weight, weekly hour long conference calls with structured interactive educational lessons led by Health Educator, dietary recalls were completed at three different time points during their participation, and study personnel monitored physical activity levels weekly.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pre-pregnancy BMI between 22 kg/m2 to 45 kg/m2
Exclusion Criteria
* Pre-eclampsia
* Hypertension
* Other metabolic abnormalities
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Kansas Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Holly R Hull, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Kansas Medical Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13749
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.